Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Double-Blind Study of AK1830 in Patients with Pain due to Osteoarthritis of the Knee
jRCT2031230469Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of AK-1830 in knee osteoarthritis (OA) and osteoarthritis (OA) (4 arms), sponsored by Asahi Kasei Corporation. Primary endpoint: Mean change from baseline on the numerical rating scale (NRS) for pain. Started Jan 2024; status: completed.
02
Drugs
AK-1830
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2031230469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230469.